Globalstar, Inc. Form 8-K Summary
Business Context and Reporting Period
Date: June 19, 2009
Company: Globalstar, Inc.
Event: Entry into material definitive agreements with principal stockholder Thermo Funding Company LLC ("Thermo") to satisfy conditions precedent for a new Facility Agreement with BNP Paribas and COFACE Agent dated June 5, 2009.
Key Financial Metrics and Agreements
This filing details capital restructuring rather than operational financial results. No revenue, profit, or cash flow data is provided in this document.
- Debt Conversion: Thermo agreed to exchange all outstanding secured debt owed by Globalstar (under the December 17, 2007 Credit Agreement) for one share of Series A Convertible Preferred Stock.
- Liquidity Support: Thermo deposited $60 million into a contingent equity account to secure Globalstar's obligations under the Facility Agreement.
- Contingent Equity Terms:
- Globalstar must draw from this account if minimum liquidity requirements are not met.
- Draws result in Thermo receiving common stock at 80% of the 15-day volume-weighted average closing price.
- Undrawn funds are returned to Thermo after the second scheduled repayment (expected by June 15, 2012).
- Thermo receives an availability fee of 10% per year, payable solely in warrants to purchase common stock at $0.01 per share.
- Preferred Stock Terms: The Series A Preferred has a $0.01 liquidation preference, no dividend preference, and is convertible into 126,174,034 shares of common stock (or nonvoting common stock).
Material Changes and Conditions
The agreements are contingent upon the initial funding under the Facility Agreement occurring by June 30, 2009. If funding does not occur by this date, the debt exchange will be void.
General limitations apply to Thermo's ability to convert preferred stock or exercise warrants:
- Conversion/exercise requires approval by a majority of common stockholders per Nasdaq Listing Rules.
- Issuance is capped if it would cause Thermo and affiliates to own more than 70% of the outstanding voting stock.
- Nonvoting common stock may be issued in lieu of voting stock to maintain this 70% cap.
Guidance, Risks, and Unusual Items
Risks and Contingencies:
- Funding Risk: The entire restructuring hinges on the Facility Agreement funding by June 30, 2009.
- Liquidity Risk: The company faces potential dilution if it fails to meet minimum liquidity requirements, triggering draws from the $60 million contingent equity account.
- Ownership Concentration: Significant ownership concentration risks exist, with Thermo potentially controlling up to 70% of voting stock.
Unusual Items: The transaction involves a unique structure where debt is converted to preferred stock and a large cash deposit is held as contingent equity with a fee paid in warrants rather than cash.
Investor Verification Checklist
- Verify whether the initial funding under the Facility Agreement occurred by the June 30, 2009 deadline.
- Confirm the current status of the $60 million contingent equity account and whether any draws have been made.
- Review the terms of the Facility Agreement with BNP Paribas to understand the specific minimum liquidity requirements.
- Monitor shareholder voting approvals required for Thermo to convert preferred stock or exercise warrants.
- Assess the impact of potential dilution from the 126,174,034 convertible shares and warrant issuances.